Angiogenesis promoters and inhibitors: potential therapeutic implications.
Mousa
S A
SA
Dupont Merck Pharmaceutical Company, Experimental Station, Wilmington, DE 19889-0400, USA. mousa@al.ll.dmpc.umc.dupont.com
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D018919:Neovascularization, Physiologic / Q000502:physiology*
D000970:Antineoplastic Agents